日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Targeting Impaired Type I Interferon-IL-27 Signaling Rescues T Regulatory Cell Suppressive Function in Relapsing-Remitting Multiple Sclerosis

靶向受损的 I 型干扰素-IL-27 信号通路可挽救复发缓解型多发性硬化症中的 T 调节细胞抑制功能

Elzoheiry, Manal; Seyedsadr, Maryam; Wrobel, John; Wang, Yan; Gopal, Sowmya Shree; Kasimoglu, Ezgi; Baeten, Paulien; Hamad, Ibrahim; Gleason, Mia Rose; Broux, Bieke; Ting, Jenny; Min, Booki; Markovic-Plese, Silva

Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives

皮下注射干扰素β-1a治疗多发性硬化症二十年:当代视角

Freedman, Mark S; Coyle, Patricia K; Hellwig, Kerstin; Singer, Barry; Wynn, Daniel; Weinstock-Guttman, Bianca; Markovic-Plese, Silva; Galazka, Andrew; Dangond, Fernando; Korich, Julie; Reder, Anthony T

Blood-based targeted metabolipidomics reveals altered omega fatty acid-derived lipid mediators in relapsing-remitting multiple sclerosis patients

基于血液的靶向代谢脂质组学揭示了复发缓解型多发性硬化症患者体内ω脂肪酸衍生的脂质介质发生改变

Zahoor, Insha; Waters, Jeffrey; Ata, Nasar; Datta, Indrani; Pedersen, Theresa L; Cerghet, Mirela; Poisson, Laila; Markovic-Plese, Silva; Rattan, Ramandeep; Taha, Ameer Y; Newman, John W; Giri, Shailendra

Corrigendum to "Oligoclonal myelin-reactive T-cell infiltrates derived from neuromyelitis optica spectrum disorder (NMOSD) lesions are enriched in Th17 cells" [Clinical Immunology 130 (2009) 133-144]

对“源自视神经脊髓炎谱系疾病 (NMOSD) 病变的寡克隆髓鞘反应性 T 细胞浸润富含 Th17 细胞”的更正 [临床免疫学 130 (2009) 133-144]

Montes, Monica; Zhang, Xin; Berthelot, Laureline; Laplaud, David-Axel; Brouard, Sophie; Jin, Jianping; Rogan, Sarah; Armao, Diane; Jewells, Valerie; Soulillou, Jean-Paul; Markovic-Plese, Silva

Therapeutic Effect of Anti-CD52 Monoclonal Antibody in Multiple Sclerosis and Its Animal Models Is Mediated via T Regulatory Cells

抗CD52单克隆抗体对多发性硬化症及其动物模型的治疗作用是通过T调节细胞介导的

Nazanin Kiapour, Bing Wu, Yan Wang, Maryamsadat Seyedsadr, Sahil Kapoor, Xin Zhang, Manal Elzoheiry, Ezgi Kasimoglu, Yisong Wan, Silva Markovic-Plese

The TGF-β superfamily cytokine Activin-A is induced during autoimmune neuroinflammation and drives pathogenic Th17 cell differentiation

TGF-β超家族细胞因子Activin-A在自身免疫性神经炎症期间被诱导,并驱动致病性Th17细胞分化。

Bing Wu ,Song Zhang ,Zengli Guo ,Yanmin Bi ,Mingxia Zhou ,Ping Li ,Maryamsadat Seyedsadr ,Xiaojiang Xu ,Jian-Liang Li ,Silva Markovic-Plese ,Yisong Y Wan

STING Agonist Mitigates Experimental Autoimmune Encephalomyelitis by Stimulating Type I IFN-Dependent and -Independent Immune-Regulatory Pathways

STING 激动剂通过刺激 I 型 IFN 依赖性和 I 型 IFN 非依赖性免疫调节通路缓解实验性自身免疫性脑脊髓炎

Brandon M Johnson, Toru Uchimura, Matthew D Gallovic, Madhan Thamilarasan, Wei-Chun Chou, Sara A Gibson, Meng Deng, Jason W Tam, Cole J Batty, Jonathan Williams, Glenn K Matsushima, Eric M Bachelder, Kristy M Ainslie, Silva Markovic-Plese, Jenny P-Y Ting

Dalfampridine for Mobility Limitations in People With Multiple Sclerosis May Be Augmented by Physical Therapy: A Non-randomized Two-Group Proof-of-Concept Pilot Study

达法吡啶治疗多发性硬化症患者行动障碍可能通过物理疗法得到增强:一项非随机双组概念验证性试点研究

Plummer, Prudence; Markovic-Plese, Silva; Giesser, Barbara

IL-11 Induces Encephalitogenic Th17 Cells in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis

IL-11 诱导多发性硬化症和实验性自身免疫性脑脊髓炎中的致脑炎 Th17 细胞

Xin Zhang, Nazanin Kiapour, Sahil Kapoor, Tabish Khan, Madhan Thamilarasan, Yazhong Tao, Stephanie Cohen, Ryan Miller, Raymond A Sobel, Silva Markovic-Plese

Case Report: Combining Dalfampridine with Multicomponent Exercise and Gait Training in a Person with Multiple Sclerosis

病例报告:达法吡啶联合多组分运动和步态训练治疗多发性硬化症患者

Plummer, Prudence; Bohling, Corinne J; Nickles, L Ellese; Williams, Alexis A; Thomas, Amy; Markovic-Plese, Silva; Giesser, Barbara